Pacira BioSciences, Inc.·4

Apr 5, 5:26 PM ET

STACK DAVID M 4

4 · Pacira BioSciences, Inc. · Filed Apr 5, 2022

Insider Transaction Report

Form 4
Period: 2022-03-31
STACK DAVID M
DirectorPresident and CEO
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2022-03-3122,50022,500 total
    Exercise: $10.81Exp: 2022-06-05Common Stock (22,500 underlying)
  • Exercise/Conversion

    Common Stock

    2022-03-31$10.81/sh+22,500$243,225145,544 total
Holdings
  • Common Stock

    (indirect: By Stack Schroon Mohawk FLP)
    18,596
  • Common Stock

    (indirect: By LLC)
    97,273
  • Common Stock

    (indirect: By LLC)
    315
Footnotes (3)
  • [F1]The option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
  • [F2]Mr. Stack and his wife are the owners of each of Three Colleens Investment, LLC and LCK Investment LLC. Mr. Stack is the general partner of Stack Schroon Mohawk FLP.
  • [F3]The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION